Literature DB >> 24223481

Role of Photodynamic Therapy for the Upper Gut.

Kenneth K Wang1.   

Abstract

It may be questioned if PDT is still relevant for practicing gastroenterologists since other types of therapy have currently gained momentum. Important aspects of PDT that continue its development are it's intrinsic applicability to the luminal GI tract where there are often areas of mechanical narrowing, unusual topography, and difficult accessibility where a modality that does not require contact or optical visualization has advantages. Although not used as often in the upper gastrointestinal tract for it's original approved indications such as esophageal cancer or Barrett's esophagus, its value in biliary lesions appears to be well substantiated. In this paper, we will review its current application in the upper gastrointestinal tract.

Entities:  

Year:  2010        PMID: 24223481      PMCID: PMC3819037          DOI: 10.1016/j.tgie.2010.01.009

Source DB:  PubMed          Journal:  Tech Gastrointest Endosc        ISSN: 1096-2883


  20 in total

1.  Endoscopic application of photodynamic therapy for cholangiocarcinoma.

Authors:  A Rumalla; T H Baron; K K Wang; G J Gores; L M Stadheim; P C de Groen
Journal:  Gastrointest Endosc       Date:  2001-04       Impact factor: 9.427

2.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial.

Authors:  Bergein F Overholt; Charles J Lightdale; Kenneth K Wang; Marcia I Canto; Steven Burdick; Roger C Haggitt; Mary P Bronner; Shari L Taylor; Michael G A Grace; Michelle Depot
Journal:  Gastrointest Endosc       Date:  2005-10       Impact factor: 9.427

3.  Characterization of apoptosis induced by photodynamic treatment with hypericin in A431 human epidermoid carcinoma cells.

Authors:  Juergen Berlanda; Tobias Kiesslich; Christian Benno Oberdanner; Franz Josef Obermair; Barbara Krammer; Kristjan Plaetzer
Journal:  J Environ Pathol Toxicol Oncol       Date:  2006       Impact factor: 3.567

4.  Hematoporphyrin derivative for detection and management of cancer.

Authors:  R L Lipson; E J Baldes; M J Gray
Journal:  Cancer       Date:  1967-12       Impact factor: 6.860

5.  Photodynamic therapy of nonresectable cholangiocarcinoma.

Authors:  M A Ortner; J Liebetruth; S Schreiber; M Hanft; U Wruck; V Fusco; J M Müller; H Hörtnagl; H Lochs
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

6.  Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial.

Authors:  C J Lightdale; S K Heier; N E Marcon; J S McCaughan; H Gerdes; B F Overholt; M V Sivak; G V Stiegmann; H R Nava
Journal:  Gastrointest Endosc       Date:  1995-12       Impact factor: 9.427

Review 7.  Achievable outcomes in the management of proximal cholangiocarcinoma: an update prepared using "evidence-based practice" techniques.

Authors:  R P M Killeen; S Harte; D Maguire; D E Malone
Journal:  Abdom Imaging       Date:  2008 Jan-Feb

Review 8.  A cost-utility analysis of ablative therapy for Barrett's esophagus.

Authors:  John M Inadomi; Ma Somsouk; Ryan D Madanick; Jennifer P Thomas; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2009-03-06       Impact factor: 22.682

9.  Photodynamic therapy induces caspase-dependent apoptosis in rat CNV model.

Authors:  Akihisa Matsubara; Toru Nakazawa; Kosuke Noda; Haicheng She; Edward Connolly; Tara A Young; Yuichiro Ogura; Evangelos S Gragoudas; Joan W Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

Review 10.  Molecular mechanisms of photodynamic therapy.

Authors:  Bernhard Ortel; Christopher R Shea; Piergiacomo Calzavara-Pinton
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.